PMC:7291971 / 12894-13094 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T303","span":{"begin":38,"end":43},"obj":"CHEBI:24433;CHEBI:24433"}],"text":") as both a protecting and activating group has been developed by Fukuyama [22]. The main advantage of this nosyl strategy is that both alkylation and deprotection proceed under mild conditions. Recen"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T115","span":{"begin":10,"end":11},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T116","span":{"begin":27,"end":37},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T117","span":{"begin":44,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T118","span":{"begin":76,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":") as both a protecting and activating group has been developed by Fukuyama [22]. The main advantage of this nosyl strategy is that both alkylation and deprotection proceed under mild conditions. Recen"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T218","span":{"begin":38,"end":43},"obj":"Chemical"}],"attributes":[{"id":"A218","pred":"chebi_id","subj":"T218","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":") as both a protecting and activating group has been developed by Fukuyama [22]. The main advantage of this nosyl strategy is that both alkylation and deprotection proceed under mild conditions. Recen"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T79","span":{"begin":81,"end":194},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":") as both a protecting and activating group has been developed by Fukuyama [22]. The main advantage of this nosyl strategy is that both alkylation and deprotection proceed under mild conditions. Recen"}